Monaco

Monaco

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.67 (0.54 - 0.78) 2019 Modelled IHME
0.7 (0.58 - 0.82) 2018 Modelled IHME
0.72 (0.59 - 0.85) 2017 Modelled IHME
0.72 (0.59 - 0.85) 2016 Modelled IHME
0.72 (0.59 - 0.86) 2015 Modelled IHME
0.73 (0.59 - 0.85) 2014 Modelled IHME
0.74 (0.60 - 0.86) 2013 Modelled IHME
0.75 (0.61 - 0.87) 2012 Modelled IHME
0.76 (0.62 - 0.88) 2011 Modelled IHME
0.77 (0.63 - 0.90) 2010 Modelled IHME
0.77 (0.63 - 0.91) 2009 Modelled IHME
0.78 (0.64 - 0.92) 2008 Modelled IHME
0.79 (0.64 - 0.93) 2007 Modelled IHME
0.8 (0.64 - 0.95) 2006 Modelled IHME
0.81 (0.64 - 0.96) 2005 Modelled IHME
0.82 (0.65 - 0.97) 2004 Modelled IHME
0.83 (0.67 - 0.97) 2003 Modelled IHME
0.84 (0.69 - 0.98) 2002 Modelled IHME
0.85 (0.70 - 0.99) 2001 Modelled IHME
0.85 (0.70 - 1.01) 2000 Modelled IHME
0.86 (0.70 - 1.01) 1999 Modelled IHME
0.87 (0.71 - 1.02) 1998 Modelled IHME
0.87 (0.70 - 1.04) 1997 Modelled IHME
0.88 (0.71 - 1.04) 1996 Modelled IHME
0.89 (0.71 - 1.06) 1995 Modelled IHME
0.89 (0.71 - 1.06) 1994 Modelled IHME
0.9 (0.72 - 1.06) 1993 Modelled IHME
0.9 (0.73 - 1.07) 1992 Modelled IHME
0.91 (0.74 - 1.08) 1991 Modelled IHME
0.91 (0.75 - 1.08) 1990 Modelled IHME
0.55 (0.04 - 7.57) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.02 (0.01 - 0.02) 2019 Modelled IHME
0.02 (0.01 - 0.02) 2018 Modelled IHME
0.02 (0.01 - 0.02) 2017 Modelled IHME
0.02 (0.01 - 0.02) 2016 Modelled IHME
0.02 (0.01 - 0.02) 2015 Modelled IHME
0.02 (0.01 - 0.02) 2014 Modelled IHME
0.02 (0.01 - 0.02) 2013 Modelled IHME
0.02 (0.01 - 0.02) 2012 Modelled IHME
0.02 (0.01 - 0.02) 2011 Modelled IHME
0.02 (0.01 - 0.03) 2010 Modelled IHME
0.02 (0.01 - 0.03) 2009 Modelled IHME
0.02 (0.01 - 0.03) 2008 Modelled IHME
0.02 (0.01 - 0.03) 2007 Modelled IHME
0.02 (0.01 - 0.03) 2006 Modelled IHME
0.02 (0.01 - 0.03) 2005 Modelled IHME
0.02 (0.01 - 0.03) 2004 Modelled IHME
0.02 (0.01 - 0.03) 2003 Modelled IHME
0.02 (0.01 - 0.03) 2002 Modelled IHME
0.02 (0.01 - 0.03) 2001 Modelled IHME
0.02 (0.01 - 0.03) 2000 Modelled IHME
0.02 (0.01 - 0.03) 1999 Modelled IHME
0.02 (0.01 - 0.03) 1998 Modelled IHME
0.02 (0.01 - 0.03) 1997 Modelled IHME
0.02 (0.01 - 0.03) 1996 Modelled IHME
0.02 (0.01 - 0.03) 1995 Modelled IHME
0.04 (0.03 - 0.05) 1994 Modelled IHME
0.09 (0.06 - 0.13) 1993 Modelled IHME
0.17 (0.11 - 0.24) 1992 Modelled IHME
0.26 (0.17 - 0.37) 1991 Modelled IHME
0.37 (0.23 - 0.52) 1990 Modelled IHME
0.2 (0.01 - 2.94) 2015 Modelled WHO
Showing out of
Show more

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
11 (8 - 17) 2019 Modelled IHME
11 (8 - 17) 2018 Modelled IHME
11 (8 - 17) 2017 Modelled IHME
11 (8 - 17) 2016 Modelled IHME
11 (8 - 17) 2015 Modelled IHME
11 (8 - 17) 2014 Modelled IHME
11 (8 - 17) 2013 Modelled IHME
11 (8 - 17) 2012 Modelled IHME
11 (8 - 17) 2011 Modelled IHME
11 (8 - 17) 2010 Modelled IHME
11 (8 - 17) 2009 Modelled IHME
11 (8 - 17) 2008 Modelled IHME
11 (8 - 17) 2007 Modelled IHME
11 (8 - 17) 2006 Modelled IHME
11 (8 - 17) 2005 Modelled IHME
12 (8 - 17) 2004 Modelled IHME
12 (8 - 17) 2003 Modelled IHME
12 (8 - 18) 2002 Modelled IHME
12 (8 - 19) 2001 Modelled IHME
13 (9 - 19) 2000 Modelled IHME
13 (9 - 19) 1999 Modelled IHME
13 (9 - 19) 1998 Modelled IHME
13 (9 - 19) 1997 Modelled IHME
13 (9 - 19) 1996 Modelled IHME
13 (9 - 19) 1995 Modelled IHME
13 (9 - 19) 1994 Modelled IHME
13 (9 - 19) 1993 Modelled IHME
13 (9 - 19) 1992 Modelled IHME
13 (9 - 19) 1991 Modelled IHME
13 (9 - 19) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
99 2018 Survey/reported WHO/UNICEF
99 2017 Survey/reported WHO/UNICEF
99 2016 Survey/reported WHO/UNICEF
99 2015 Survey/reported WHO/UNICEF
99 2014 Survey/reported WHO/UNICEF
99 2013 Survey/reported WHO/UNICEF
99 2012 Survey/reported WHO/UNICEF
99 2011 Survey/reported WHO/UNICEF
99 2010 Survey/reported WHO/UNICEF
99 2009 Survey/reported WHO/UNICEF
99 2008 Survey/reported WHO/UNICEF
99 2007 Survey/reported WHO/UNICEF
99 2006 Survey/reported WHO/UNICEF
99 2005 Survey/reported WHO/UNICEF
99 2004 Survey/reported WHO/UNICEF
99 2003 Survey/reported WHO/UNICEF
99 2002 Survey/reported WHO/UNICEF
99 2001 Survey/reported WHO/UNICEF
99 2000 Survey/reported WHO/UNICEF
99 1999 Survey/reported WHO/UNICEF
Showing out of
Show more
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.11 (0.90 - 1.36) 2019 Modelled IHME
1.11 (0.90 - 1.37) 2018 Modelled IHME
1.1 (0.90 - 1.37) 2017 Modelled IHME
1.09 (0.89 - 1.35) 2016 Modelled IHME
1.08 (0.89 - 1.33) 2015 Modelled IHME
1.08 (0.89 - 1.33) 2014 Modelled IHME
1.09 (0.89 - 1.33) 2013 Modelled IHME
1.09 (0.89 - 1.34) 2012 Modelled IHME
1.09 (0.89 - 1.34) 2011 Modelled IHME
1.09 (0.89 - 1.33) 2010 Modelled IHME
1.09 (0.89 - 1.33) 2009 Modelled IHME
1.08 (0.89 - 1.33) 2008 Modelled IHME
1.08 (0.88 - 1.32) 2007 Modelled IHME
1.07 (0.87 - 1.32) 2006 Modelled IHME
1.06 (0.86 - 1.31) 2005 Modelled IHME
1.05 (0.86 - 1.29) 2004 Modelled IHME
1.04 (0.85 - 1.28) 2003 Modelled IHME
1.03 (0.84 - 1.26) 2002 Modelled IHME
1.02 (0.84 - 1.26) 2001 Modelled IHME
1.01 (0.83 - 1.23) 2000 Modelled IHME
1 (0.82 - 1.22) 1999 Modelled IHME
0.98 (0.80 - 1.20) 1998 Modelled IHME
0.97 (0.79 - 1.19) 1997 Modelled IHME
0.95 (0.78 - 1.18) 1996 Modelled IHME
0.94 (0.77 - 1.16) 1995 Modelled IHME
0.93 (0.77 - 1.15) 1994 Modelled IHME
0.93 (0.76 - 1.14) 1993 Modelled IHME
0.92 (0.75 - 1.13) 1992 Modelled IHME
0.91 (0.74 - 1.12) 1991 Modelled IHME
0.91 (0.74 - 1.11) 1990 Modelled IHME
Showing out of
Show more

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
41 (31 - 52) 2019 Modelled IHME
41 (32 - 52) 2018 Modelled IHME
41 (32 - 51) 2017 Modelled IHME
41 (31 - 52) 2016 Modelled IHME
41 (31 - 51) 2015 Modelled IHME
41 (31 - 51) 2014 Modelled IHME
41 (31 - 51) 2013 Modelled IHME
42 (31 - 51) 2012 Modelled IHME
42 (31 - 51) 2011 Modelled IHME
42 (32 - 52) 2010 Modelled IHME
42 (32 - 52) 2009 Modelled IHME
42 (32 - 52) 2008 Modelled IHME
42 (32 - 52) 2007 Modelled IHME
42 (32 - 52) 2006 Modelled IHME
42 (32 - 52) 2005 Modelled IHME
42 (31 - 52) 2004 Modelled IHME
42 (31 - 52) 2003 Modelled IHME
42 (31 - 52) 2002 Modelled IHME
41 (31 - 52) 2001 Modelled IHME
41 (30 - 52) 2000 Modelled IHME
41 (30 - 51) 1999 Modelled IHME
41 (30 - 51) 1998 Modelled IHME
41 (30 - 51) 1997 Modelled IHME
41 (30 - 51) 1996 Modelled IHME
41 (31 - 51) 1995 Modelled IHME
41 (30 - 51) 1994 Modelled IHME
41 (30 - 51) 1993 Modelled IHME
41 (30 - 51) 1992 Modelled IHME
41 (30 - 51) 1991 Modelled IHME
41 (30 - 51) 1990 Modelled IHME
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
0.67 (%)
2019
(0.54 - 0.78(%))
IHME
HCV (RNA/cAg+)
1.11 (%)
2019
(0.9 - 1.36(%))
IHME

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
1
2019
(1 - 2)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
4
2019
(3 - 6)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.02 (%)
2019, latest modelled
(0.01 - 0.02(%))
IHME

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines